Pfizer's Lyrica Update Infringes Patent, Sun Pharma Says
Indian drugmaker Sun Pharma on Friday accused Pfizer Inc. of ripping off its patent with a new formulation of its blockbuster muscle and nerve pain drug Lyrica....To view the full article, register now.
Already a subscriber? Click here to view full article